Epidemiology of Clostridioides difficile Infection in Argentina and Associated Risk Factors Evaluated Through a Meta-Analysis
Authors:
- Angela María BarberoABAngela María Barbero
- Nicolás Diego MoriconiNMNicolás Diego Moriconi
- Sabina PalmaSPSabina Palma
- Josefina CelanoJCJosefina Celano
- María Gracia BalbiMBMaría Gracia Balbi
- Lorenzo Sebastián MorroLMLorenzo Sebastián Morro
- María Martina Calvo ZarlengaMZMaría Martina Calvo Zarlenga
- Jorgelina SuárezJSJorgelina Suárez
- María Guadalupe MartínezMMMaría Guadalupe Martínez
- Mónica Graciela MachainMMMónica Graciela Machain
- Carlos Gabriel AltamirandaCACarlos Gabriel Altamiranda
- Gabriel ErbitiGEGabriel Erbiti
Open Access
- 22 May 2026
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 15 (6) , 528
Abstract
Background: Clostridioides difficile is classified within the first 18 threats for antimicrobial resistance and is the leading cause of hospital-acquired enteric infection. Community-associated cases have notably increased in recent decades, highlighting that accurate and up-to-date statistics characterizing the epidemiology of C. difficile infection (CDI) are critical. Methods: We conducted a retrospective (2019–2023) case-control study evaluating the prevalence of CDI in 249 stool samples from hospitalized patients in the sanitary region III of Buenos Aires, Argentina. The presence of C. difficile was detected by combining EIA, PCR, and toxigenic culture via a diagnostic algorithm. Clinical and demographic data from patients were analyzed to identify CDI-associated risk factors. We also conducted a systematic review and a meta-analysis contrasting our results with 38 studies selected from different countries. Results: One in five patients presented C. difficile as the etiological agent of diarrhea. Eighty percent of the CDI+ cases carried toxigenic strains, with a third of cases associated with community environments. Age ≥ 69 years, previous use of antibiotics, previous hospitalization, and previous episodes of CDI emerged as predisposing factors for CDI in our study cohort. In an exploratory evaluation of clinical data, CDI+ patients showed higher leukocytes and platelets counts, a decreased basophil count, and increased urea concentration. At the global level, the meta-analysis reinforced advanced age, previous consumption of antibiotics, previous consumption of proton pump inhibitors, previous hospitalization, and previous CDI as risk factors for CDI. Conclusions: These results emphasize the importance of continued epidemiological surveillance of CDI. Our findings confirm previously described risk factors, both in our cohort and at the global level. Exploratory alterations in laboratory parameters were observed, although their clinical relevance and specificity require further investigation.Keywords
Funding Information
- Universidad Nacional del Noroeste de la Provincia de Buenos Aires (SIB 0618/2019)
- Universidad Nacional del Noroeste de la Provincia de Buenos Aires (SIB 2113/2022)
- Universidad Nacional del Noroeste de la Provincia de Buenos Aires (Res. CS 2190/2022)
- Agencia Nacional de Promoción Científica y Tecnológica, Fondo para la Investigación Científica y Tecnológica (PICT A 2017-1896)
- Agencia Nacional de Promoción Científica y Tecnológica, Fondo para la Investigación Científica y Tecnológica (PICT-2021-I-A-01119)
- Agencia Nacional de Promoción Científica y Tecnológica, Fondo para la Investigación Científica y Tecnológica (PICT 2018-03084 IB)
- Agencia Nacional de Promoción Científica y Tecnológica, Fondo para la Investigación Científica y Tecnológica (PICT-2021-I-INVI-00584)
- Agencia Nacional de Promoción Científica y Tecnológica, Fondo para la Investigación Científica y Tecnológica (PICT-2021-I-INVI-00208)
- UNNOBA FONCyT (PICTO 2019-00007)
- Consejo Nacional de Investigaciones Científicas y Técnicas (PIP 2021 11220200103137CO)
This publication has 134 references indexed in Scilit:
- Clostridioides Difficile in Latin America: An Epidemiological OverviewCurrent Microbiology, 2023
- Clinical Predictors of Recurrence After Primary Clostridioides difficile Infection: A Prospective Cohort StudyDigestive Diseases and Sciences, 2019
- Clostridium difficile infection: reviewEuropean Journal of Clinical Microbiology & Infectious Diseases, 2019
- Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut MicrobiomeNutrition in Clinical Practice, 2018
- Clinical characteristics of Clostridium difficile infection in hospitalized patients with antibiotic-associated diarrhea in a university hospital in ChinaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2014
- Epidemiology of Community-AssociatedClostridium difficileInfection, 2009 Through 2011JAMA Internal Medicine, 2013
- Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case–control studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2012
- Acid-Suppressive Medication Use and the Risk for Hospital-Acquired PneumoniaJAMA, 2009
- Predictors of Mortality After Colectomy for Fulminant Clostridium difficile ColitisArchives of Surgery, 2008
- Use of Gastric Acid–Suppressive Agents and the Risk of Community-Acquired Clostridium difficile–Associated DiseaseJAMA, 2005